Lataa...
Strategies For Targeting Chronic Myeloid Leukaemia Stem Cells
Chronic Myeloid Leukaemia is a myeloproliferative disorder driven by the t(9;22) chromosomal translocation coding for the chimeric protein BCR-ABL. CML treatment represents the paradigm of molecular therapy of cancer. Since the development of the tyrosine kinase inhibitor of the BCR-ABL kinase, the...
Tallennettuna:
| Julkaisussa: | Blood Lymphat Cancer |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6842740/ https://ncbi.nlm.nih.gov/pubmed/31807112 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BLCTT.S228815 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|